Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-sensitive Prostate Cancer

Urology. 2017 Nov:109:1-2. doi: 10.1016/j.urology.2017.07.032. Epub 2017 Aug 7.

Authors

Werner J Struss¹, Peter C Black¹

Affiliation

¹ Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.

PMID: 28797683
DOI: 10.1016/j.urology.2017.07.032

No abstract available

Publication types

Letter
Comment

MeSH terms

Abiraterone Acetate
Androstenes*
Antineoplastic Combined Chemotherapy Protocols
Castration
Disease-Free Survival
Humans
Male
Neoplasm Metastasis
Prednisolone*
Prednisone
Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant
Taxoids

Substances

Androstenes
Taxoids
Prednisolone
Abiraterone Acetate
abiraterone
Prednisone